CytomX Therapeutics
Develops tumor-localized, conditionally activated oncology biologics through its PROBODY platform.
$3.20
After-hours close−0.01 (−0.47%)
At close$3.22(−5.99%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.09 | — | — |
| Aug 2026 | −$0.08 | −$0.09 | −16.8% |
| May 2026 | −$0.14 | −$0.10 | +28.6% |
| Mar 2026 | −$0.08 | −$0.22 | −175.0% |
| Nov 2025 | −$0.05 | −$0.09 | −82.5% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Feb 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Feb 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Jun 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 5, 2026 | −$0.09 | — | — | $10.4M | — | — |
| Aug 6, 2026 | −$0.08 | −$0.09 | −16.8% | $12.4M | $1.4M | −88.6% |
| May 7, 2026 | −$0.14 | −$0.10 | +28.6% | $4.7M | $10.3M | +119.1% |
| Mar 16, 2026 | −$0.08 | −$0.22 | −175.0% | $7.3M | $661.0K | −91.0% |
| Nov 6, 2025 | −$0.05 | −$0.09 | −82.5% | $7.3M | $6.0M | −18.6% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | ||||||
| Aug 7, 2025 | ||||||
| May 12, 2025 | ||||||
| Mar 6, 2025 | ||||||
| Nov 7, 2024 | ||||||
| Aug 8, 2024 | ||||||
| May 8, 2024 | ||||||
| Mar 11, 2024 | ||||||
| Nov 7, 2023 | ||||||
| Aug 8, 2023 | ||||||
| May 9, 2023 | ||||||
| Mar 27, 2023 | ||||||
| Nov 8, 2022 | ||||||
| Aug 4, 2022 | ||||||
| May 5, 2022 | ||||||
| Mar 1, 2022 | ||||||
| Nov 4, 2021 | ||||||
| Aug 5, 2021 | ||||||
| May 6, 2021 | ||||||
| Feb 24, 2021 | ||||||
| Nov 5, 2020 | ||||||
| Aug 6, 2020 | ||||||
| May 7, 2020 | ||||||
| Feb 27, 2020 | ||||||
| Nov 7, 2019 | ||||||
| Aug 7, 2019 | ||||||
| May 9, 2019 | ||||||
| Feb 27, 2019 | ||||||
| Nov 6, 2018 | ||||||
| Aug 8, 2018 | ||||||
| May 9, 2018 | ||||||
| Mar 7, 2018 | ||||||
| Nov 7, 2017 | ||||||
| Aug 7, 2017 | ||||||
| May 5, 2017 | ||||||
| Mar 2, 2017 | ||||||
| Nov 3, 2016 | ||||||
| Aug 3, 2016 | ||||||
| May 6, 2016 | ||||||
| Mar 7, 2016 | ||||||
| Nov 23, 2015 | ||||||
| Jun 30, 2015 | ||||||